Assessment of Wound Care Product Skin Adhesion
SWAP
1 other identifier
interventional
48
1 country
1
Brief Summary
The purpose of this exploratory study is to assess the adhesive forces to skin of samples over the period of 24 hours to establish the peel-off measurement method at the Essity study site.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 11, 2026
CompletedSeptember 2, 2025
August 1, 2025
1 month
August 15, 2025
August 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adhesion
Medical tape sample's adhesion force to skin measured in Newton-centimeter
After 24 hours of tape use
Adhesive forces measured in N/cm
1-2 months
Study Arms (1)
Experimental Group Tape wearing
EXPERIMENTALSixteen samples of different test materials (medical tape) will be placed on the participant's upper and lower back. This ingle group acts as it's own control.
Interventions
The purpose of this exploratory study is to assess the adhesion to skin properties of test material samples over 24 hours to establish the peel-off measurement method at the new Essity study site. As the performance and safety of the tapes, WAFs and post-OPs in its intended use are not tested in the current study it is not considered a medical device study according to EU medical device regulation (MDR) 2017/745
Eligibility Criteria
You may qualify if:
- The participants must meet all of the following criteria to be eligible to participate in the investigation:
- Written informed consent to participate in the study.
- Willingness to actively participate in the study and to come to the scheduled visits.
- Female and/or male.
- From 18 to 70 years of age.
- Minimal hairiness on the back (the test area)
You may not qualify if:
- Participants meeting any of the following criteria will not be permitted to participate in the investigation:
- Female participants: Pregnancy or lactation.
- Drug or alcohol addiction.
- AIDS, HIV-positive or infectious hepatitis.
- Conditions which exclude a participation or might influence the test reaction/evaluation.
- Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area.
- Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years.
- Diabetes mellitus (type 1 and 2).
- Active skin disease at the test area.
- Documented allergies to dressings in particular with acrylates and natural rubber (latex).
- Wounds, moles, tattoos, scars, irritated skin at the test area that could influence the investigation.
- Any topical medication at the test area within the last 24 hours prior to the start of the study and/or throughout the entire course of the study.
- Application of cosmetics (e.g. creams, lotions, sunscreens) to the test area within the last 3 days prior to start of the study.
- Showering at the day of study start.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Essity Study Site
Mölndal, VGR, 43131, Sweden
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2025
First Posted
August 22, 2025
Study Start
September 1, 2025
Primary Completion
October 1, 2025
Study Completion
February 11, 2026
Last Updated
September 2, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
IPD data will be only used internally by Essity and not be shared with other researchers.